Background incidence rates from electronic healthcare databases for vaccine safety monitoring: review of challenges from the COVID-19 vaccination campaign and proposal for best practices.
Saved in:
| Title: | Background incidence rates from electronic healthcare databases for vaccine safety monitoring: review of challenges from the COVID-19 vaccination campaign and proposal for best practices. |
|---|---|
| Authors: | Gandhi-Banga S; Epidemiology and Benefit Risk, Patient Safety and Pharmacovigilance, Sanofi, Toronto, ON, Canada., Serradell L; Epidemiology and Benefit Risk, Patient Safety and Pharmacovigilance, Sanofi, Lyon, France., Layton D; PEPI Consultancy Limited, Southampton, United Kingdom., Dreyfus J; Global Medical Epidemiology, Pfizer, Inc, New York, NY, United States., Praet N; Global Epidemiology Organization, Johnson and Johnson, Beerse, Belgium., Garofalo DC; Global Medical Epidemiology, Pfizer, Inc, New York, NY, United States., Bauchau V; Independent, Previously Vaccine Safety, GlaxoSmithKline (GSK), Wavre, Belgium., Kelly SP; Global Medical Epidemiology, Pfizer, Inc, New York, NY, United States., Li L; Epidemiology and Benefit Risk, Patient Safety and Pharmacovigilance, Sanofi, Morristown, NJ, United States. |
| Source: | Frontiers in drug safety and regulation [Front Drug Saf Regul] 2025 Dec 01; Vol. 5, pp. 1651090. Date of Electronic Publication: 2025 Dec 01 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9919033103806676 Publication Model: eCollection Cited Medium: Internet ISSN: 2674-0869 (Electronic) Linking ISSN: 26740869 NLM ISO Abbreviation: Front Drug Saf Regul Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41404127 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Background incidence rates from electronic healthcare databases for vaccine safety monitoring: review of challenges from the COVID-19 vaccination campaign and proposal for best practices. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gandhi-Banga+S%22">Gandhi-Banga S</searchLink>; Epidemiology and Benefit Risk, Patient Safety and Pharmacovigilance, Sanofi, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Serradell+L%22">Serradell L</searchLink>; Epidemiology and Benefit Risk, Patient Safety and Pharmacovigilance, Sanofi, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Layton+D%22">Layton D</searchLink>; PEPI Consultancy Limited, Southampton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dreyfus+J%22">Dreyfus J</searchLink>; Global Medical Epidemiology, Pfizer, Inc, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Praet+N%22">Praet N</searchLink>; Global Epidemiology Organization, Johnson and Johnson, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Garofalo+DC%22">Garofalo DC</searchLink>; Global Medical Epidemiology, Pfizer, Inc, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Bauchau+V%22">Bauchau V</searchLink>; Independent, Previously Vaccine Safety, GlaxoSmithKline (GSK), Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Kelly+SP%22">Kelly SP</searchLink>; Global Medical Epidemiology, Pfizer, Inc, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Epidemiology and Benefit Risk, Patient Safety and Pharmacovigilance, Sanofi, Morristown, NJ, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229919033103806676%22">Frontiers in drug safety and regulation</searchLink> [Front Drug Saf Regul] 2025 Dec 01; Vol. 5, pp. 1651090. <i>Date of Electronic Publication: </i>2025 Dec 01 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9919033103806676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2674-0869 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226740869%22">26740869 </searchLink><i>NLM ISO Abbreviation: </i>Front Drug Saf Regul <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41404127 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fdsfr.2025.1651090 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1651090 Titles: – TitleFull: Background incidence rates from electronic healthcare databases for vaccine safety monitoring: review of challenges from the COVID-19 vaccination campaign and proposal for best practices. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gandhi-Banga S – PersonEntity: Name: NameFull: Serradell L – PersonEntity: Name: NameFull: Layton D – PersonEntity: Name: NameFull: Dreyfus J – PersonEntity: Name: NameFull: Praet N – PersonEntity: Name: NameFull: Garofalo DC – PersonEntity: Name: NameFull: Bauchau V – PersonEntity: Name: NameFull: Kelly SP – PersonEntity: Name: NameFull: Li L IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2674-0869 Numbering: – Type: volume Value: 5 Titles: – TitleFull: Frontiers in drug safety and regulation Type: main |
| ResultId | 1 |